References
1. O’Boyle JD, Coleman RL, Bernstein SG, Lifshitz S, Muller CY, Miller
DS. Intraoperative lymphatic mapping in cervix cancer patients
undergoing radical hysterectomy: A pilot study. Gynecol Oncol2000; 79 (2): 238-43.
2. Frumovitz M, Plante M, Lee PS, et al. Near-infrared fluorescence for
detection of sentinel lymph nodes in women with cervical and uterine
cancers (FILM): a randomised, phase 3, multicentre, non-inferiority
trial. The Lancet Oncology 2018; 19 (10): 1394-403.
3. Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection
versus no dissection in patients with sentinel lymph node biopsy
positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.The Lancet Oncology 2016; 17 (6): 757-67.
4. Rossi EC, Kowalski LD, Scalici J, et al. A comparison of sentinel
lymph node biopsy to lymphadenectomy for endometrial cancer staging
(FIRES trial): a multicentre, prospective, cohort study. The
Lancet Oncology 2017; 18 (3): 384-92.
5. Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no
axillary dissection in patients with breast cancer and sentinel-node
micrometastases (IBCSG 23-01): 10-year follow-up of a randomised,
controlled phase 3 trial. The Lancet Oncology 2018;19 (10): 1385-93.
6. Niikura H, Okamoto S, Otsuki T, et al. Prospective study of sentinel
lymph node biopsy without further pelvic lymphadenectomy in patients
with sentinel lymph node-negative cervical cancer. Int J Gynecol
Cancer 2012; 22 (7): 1244-50.
7. Mathevet P, Lecuru F, Magaud L, Bouttitie F. Sentinel lymph node
biopsy for early cervical cancer: Results of a randomized prospective,
multicenter study (Senticol 2) comparing adding pelvic lymph node
dissection vs sentinel node biopsy only. Gynecol Oncol 2017;145 : 2-3.
8. Balaya V, Mathevet P, Magaud L, et al. Predictive factors of
unexpected lymphatic drainage pathways in early-stage cervical cancer.Gynecol Oncol 2019; 154 (1): 102-9.
9. Sniadecki M, Wydra DG, Wojtylak S, et al. The impact of low volume
lymph node metastases and stage migration after pathologic ultrastaging
of non-sentinel lymph nodes in early-stage cervical cancer: a study of
54 patients with 4.2 years of follow up. Ginekol Pol 2019;90 (1): 20-30.
10. Guani B, Dorez M, Magaud L, Buenerd A, Lecuru F, Mathevet P. Impact
of micrometastasis or isolated tumor cells on recurrence and survival in
patients with early cervical cancer: SENTICOL Trial. Int J Gynecol
Cancer 2019; 29 (3): 447-52.
11. Barranger E, Cortez A, Commo F, et al. Histopathological validation
of the sentinel node concept in cervical cancer. Ann Oncol 2004;15 (6): 870-4.
12. Selman TJ, Mann C, Zamora J, Appleyard TL, Khan K. Diagnostic
accuracy of tests for lymph node status in primary cervical cancer: a
systematic review and meta-analysis. CMAJ 2008; 178 (7):
855-62.
13. NCCN-National Comprehensive Cancer Network. NCCN Clinical Practice
Guidelines in Oncology: Cervical Cancer. Version 1.2019.
14. Dostalek L, Åvall-Lundqvist E, Creutzberg CL, et al. ESGO survey on
current practice in the management of cervical cancer. Int J
Gynecol Cancer 2018; 28 (6): 1226-31.
15. Yahata H, Kobayashi H, Sonoda K, et al. Prognostic outcome and
complications of sentinel lymph node navigation surgery for early-stage
cervical cancer. Int J Clin Oncol 2018; 23 (6): 1167-72.
16. Vercellino GF, Erdemoglu E, Lichtenberg P, et al. A GCIG
international survey: clinical practice patterns of sentinel lymph node
biopsies in cervical cancer. Arch Gynecol Obstet 2019;300 (1): 191-9.
17. Tax C, Rovers MM, de Graaf C, Zusterzeel PL, Bekkers RL. The
sentinel node procedure in early stage cervical cancer, taking the next
step; a diagnostic review. Gynecol Oncol 2015; 139 (3):
559-67.
18. Cibula D, McCluggage WG. Sentinel lymph node (SLN) concept in
cervical cancer: Current limitations and unanswered questions.Gynecol Oncol 2019; 152 (1): 202-7.
19. Bhatla N, Aoki D, Sharma D, Sankaranarayanan R. FIGO Cancer Report
2018. Cancer of the cervix uteri. Int J Gynecol Obstet 2018;143 (143): 22-36.
20. Baker P, Oliva E. A practical approach to intraoperative
consultation in gynecological pathology. Int J Gynecol Pathol2008; 27 (3): 353-65.
21. Okamoto S, Niikura H, Nakabayashi K, et al. Detection of sentinel
lymph node metastases in cervical cancer: assessment of KRT19 mRNA in
the one-step nucleic acid amplification (OSNA) method. Gynecol
Oncol 2013; 130 (3): 530-6.
22. Lee YS, Rhim CC, Lee HN, Lee KH, Park JS, Namkoong SE. HPV status in
sentinel nodes might be a prognostic factor in cervical cancer.Gynecol Oncol 2007; 105 (2): 351-7.
23. Kohler C, Le X, Dogan NU, et al. Molecular diagnosis for nodal
metastasis in endoscopically managed cervical cancer: the accuracy of
the APTIMA test to detect high-risk human papillomavirus messenger RNA
in sentinel lymph nodes. J Minim Invasive Gynecol 2016;23 (5): 748-52.
24. Marchiolè P, Buenerd A, Scoazec JY, Dargent D, Mathevet P. Sentinel
lymph node biopsy is not accurate in predicting lymph node status for
patients with cervical carcinoma. Cancer 2004; 100 (10):
2154-9.
25. Fader AN, Edwards RP, Cost M, et al. Sentinel lymph node biopsy in
early-stage cervical cancer: utility of intraoperative versus
postoperative assessment. Gynecol Oncol 2008; 111 (1):
13-7.
26. Bats AS, Buenerd A, Querleu D, et al. Diagnostic value of
intraoperative examination of sentinel lymph node in early cervical
cancer: a prospective, multicenter study. Gynecol Oncol 2011;123 (2): 230-5.
27. Diaz JP, Gemignani ML, Pandit-Taskar N, et al. Sentinel lymph node
biopsy in the management of early-stage cervical carcinoma.Gynecol Oncol 2011; 120 (3): 347-52.
28. Roy M, Bouchard-Fortier G, Popa I, et al. Value of sentinel node
mapping in cancer of the cervix. Gynecol Oncol 2011;122 (2): 269-74.
29. Slama J, Dundr P, Dusek L, Cibula D. High false negative rate of
frozen section examination of sentinel lymph nodes in patients with
cervical cancer. Gynecol Oncol 2013; 129 (2): 384-8.
30. Yamashita T, Katayama H, Kato Y, et al. Management of pelvic lymph
nodes by sentinel node navigation surgery in the treatment of invasive
cervical cancer. Int J Gynecol Cancer 2009; 19 (6):
1113-8.
31. Klapdor R, Mucke J, Schneider M, et al. Value and advantages of
preoperative sentinel lymph node imaging with SPECT/CT in cervical
cancer. Int J Gynecol Cancer 2014; 24 (2): 295-302.
32. Deng XY, Zhang Y, Li DP, et al. Abdominal radical trachelectomy
guided by sentinel lymph node biopsy for stage IB1 cervical cancer with
tumors >2 cm. Oncotarget 2017; 8 (2):
3422-9.
33. Sonoda K, Yahata H, Okugawa K, et al. Value of intraoperative
cytological and pathological sentinel lymph node diagnosis in
fertility-sparing trachelectomy for early-stage cervical cancer.Oncology 2018; 94 (2): 92-8.
34. Papadia A, Morosi C, Wang J, et al. SLN mapping in early-stage
cervical cancer as a minimal-invasive triaging tool for multimodal
treatment. Eur J Surg Oncol 2019; 45 (4): 679-83.
35. Darlin L, Persson J, Bossmar T, et al. The sentinel node concept in
early cervical cancer performs well in tumors smaller than 2 cm.Gynecol Oncol 2010; 117 (2): 266-9.
36. Lecuru FR, McCormack M, Hillemanns P, et al. SENTICOL III: an
international validation study of sentinel node biopsy in early cervical
cancer. A GINECO, ENGOT, GCIG and multicenter study. Int J Gynecol
Cancer 2019; 29 (4): 829-34.
37. Cibula D, Dusek J, Jarkovsky J, et al. A prospective multicenter
trial on sentinel lymph node biopsy in patients with early-stage
cervical cancer (SENTIX). Int J Gynecol Cancer 2019;29 (1): 212-5.
38. van Diest PJ. Histopathological workup of sentinel lymph nodes: how
much is enough? J Clin Pathol 1999; 52 : 871–3.
39. Rhim CC, Jong-Sup P, Seog-Nyeon B, Sung-Eun NJJoKMS. Sentinel node
biopsy as an indicator for pelvic nodes dissection in early stage
cervical cancer. J Korean Med Sci 2002; 17 (4): 507-11.
40. Lambaudie E, Collinet P, Narducci F, et al. Laparoscopic
identification of sentinel lymph nodes in early stage cervical cancer.Gynecol Oncol 2003; 89 (1): 84-7.
41. Sheng XG, Li DP, Liu NF, et al. Clinical significance of sentinel
lymph nodes detection in patients with early stage cervical cancer.Chin J Obstet Gynecol 2004; 36 (1): 10-3.
42. Pijpers R, Buist MR, van Lingen A, et al. The sentinel node in
cervical cancer: scintigraphy and laparoscopic gamma probe-guided
biopsy. Eur J Nucl Med Mol Imaging 2004; 31 (11):
1479-86.
43. Schwendinger V, Müller-Holzner E, Zeimet AG, Marth C. Sentinel node
detection with the blue dye technique in early cervical cancer.Eur J Gynaecol Oncol 2006; 27 (4): 359-62.
44. Altgassen C, Paseka A, Urbanczyk H, et al. Dilution of dye improves
parametrial SLN detection in patients with cervical cancer.Gynecol Oncol 2007; 105 (2): 329-34.
45. Kushner DM, Connor JP, Wilson MA, et al. Laparoscopic sentinel lymph
node mapping for cervix cancer–a detailed evaluation and time
analysis. Gynecol Oncol 2007; 106 (3): 507-12.
46. Lou HM, Lv WG, Xie X, et al. Sentinel lymph node detection and
intraoperational diagnosis in patients with early stage cervical cancer.Natl Med J Chin 2007; 87 (47): 3353-6.
47. Seong SJ, Park H, Yang KM, et al. Detection of sentinel lymph nodes
in patients with early stage cervical cancer. J Korean Med Sci2007; 22 (1): 105-9.
48. Pluta M, Rob L, Charvat M, et al. Less radical surgery than radical
hysterectomy in early stage cervical cancer: a pilot study.Gynecol Oncol 2009; 113 (2): 181-4.
49. Gortzak-Uzan L, Jimenez W, Nofech-Mozes S, et al. Sentinel lymph
node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer:
is it time to change the gold standard? Gynecol Oncol 2010;116 (1): 28-32.
50. Du XL, Sheng XG, Jiang T, et al. Sentinel lymph node biopsy as
guidance for radical trachelectomy in young patients with early stage
cervical cancer. BMC Cancer 2011; 11 : 157.
51. Póka R, Molnar S, Daragó P, et al. Intention-to-treat analysis of
radical trachelectomy for early-stage cervical cancer with special
reference to oncologic failures: single-institutional experience in
Hungary. Int J Gynecol Cancer 2017; 27 (7): 1438-45.
52. Tanaka T, Terai Y, Ashihara K, et al. The detection of sentinel
lymph nodes in laparoscopic surgery for uterine cervical cancer using
99m-technetium-tin colloid, indocyanine green, and blue dye. J
Gynecol Oncol 2017; 28 (2): e13.
53. García JC, de la Riva Pérez PA, Jiménez IR, et al. Selective biopsy
of the sentinel node in cancer of cervix: Experience in validation
phase. Rev Esp Med Nucl Imagen Mol 2018; 37 (6): 359-65.
54. Poling JS, Tsangaris TN, Argani P, Cimino-Mathews A. Frozen section
evaluation of breast carcinoma sentinel lymph nodes: a retrospective
review of 1,940 cases. Breast Cancer Res Treat 2014;148 (2): 355-61.
55. Park JY, Kook MC, Eom BW, et al. Practical intraoperative pathologic
evaluation of sentinel lymph nodes during sentinel node navigation
surgery in gastric cancer patients - Proposal of the pathologic protocol
for the upcoming SENORITA trial. Surg Oncol 2016; 25 (3):
139-46.
56. Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or
surgery of the axilla after a positive sentinel node in breast cancer
(EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase
3 non-inferiority trial. The Lancet Oncology 2014;15 (12): 1303-10.
57. Bishop JA, Sun J, Ajkay N, Sanders MA. Decline in frozen section
diagnosis for axillary sentinel lymph nodes as a result of the American
College of Surgeons Oncology Group Z0011 Trial. Arch Pathol Lab
Med 2016; 140 (8): 830-5.
58. Abu-Rustum NR, Neubauer N, Sonoda Y, et al. Surgical and pathologic
outcomes of fertility-sparing radical abdominal trachelectomy for FIGO
stage IB1 cervical cancer. Gynecol Oncol 2008; 111 (2):
261-4.
59. Cibula D, Abu-Rustum NR, Dusek L, et al. Prognostic significance of
low volume sentinel lymph node disease in early-stage cervical cancer.Gynecol Oncol 2012; 124 (3): 496-501.
60. Fregnani J, Latorre M, Novik P, Lopes A, Soares F. Assessment of
pelvic lymph node micrometastatic disease in stages IB and IIA of
carcinoma of the uterine cervix. Int J Gynecol Cancer 2006;16 : 1188-94.
61. Okamoto S, Niikura H, Yoshinaga K, et al. Detection of
micrometastases in cervical cancer with a system that evaluates both
sentinel and nonsentinel lymph nodes. Int J Gynecol Cancer 2009;19 (4): 708-11.